RQT-18229-78343 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-22
Dose 1 — Pfizer-BioNTech
2022-06-23
Registered in v-safe
2022-06-23
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-24
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-25
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-26
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-27
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-28
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Fever · Sleepiness

Under 3 check-in
2022-06-29
Survey response — day 7, dose 1, under 3
MedDRA: Hand-foot-and-mouth disease, Rash erythematous — Feeling: Fair · Fever · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: He has red bumps on his body and was diagnosed with Hand, Foot, and Mouth Disease

MedDRA releases: 2024-11 · check-in free text available
2022-06-29
Report sent to call center — day 7, dose 1, under 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-06-30
Call successful
Not applicable - Accidental Reporting
2022-07-06
Survey response — day 14, dose 1, under 3
MedDRA: Cough — Feeling: Fair

Free text: Cough

MedDRA releases: 2024-11 · check-in free text available
2022-07-13
Survey response — day 21, dose 1, under 3
MedDRA: Cough, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school

Free text: Cough, runny nose

MedDRA releases: 2024-11 · check-in free text available
2022-07-23
Health check-in — day 28, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-29
Health check-in — day 35, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-08-04
Survey response — day 42, dose 1, under 3
MedDRA: Cough — Feeling: Fair

Free text: Cough

MedDRA releases: 2024-11 · check-in free text available
2022-09-22
Health check-in — 3 months, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-12-23
Health check-in — 6 months, dose 1, under 3
Feeling: Good

Under 3 check-in
2023-06-24
Health check-in — 12 months, dose 1, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-22	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-06-29	Successful 2022-06-30	Not applicable - Accidental Reporting

Free text

Release 12 (Under 3) — day 7, dose 1, under 3

2022-06-29

Systemic reaction (other): He has red bumps on his body and was diagnosed with Hand, Foot, and Mouth Disease

Release 12 (Under 3) — day 14, dose 1, under 3

2022-07-06

Symptoms: Cough

Release 12 (Under 3) — day 21, dose 1, under 3

2022-07-13

Symptoms: Cough, runny nose

Release 12 (Under 3) — day 42, dose 1, under 3

2022-08-04

Symptoms: Cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Rhinorrhoea	·	·	✓
SRO	Hand-foot-and-mouth disease	·	·	✓
SRO	Rash erythematous	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release